Showing results (61-70 of 7,248) with videos related to
Sort By:
Pageof 725
Journal of Cardiovascular Pharmacology|June 24, 2011
Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseasesEva H C Tang, Peter Libby, Paul M Vanhoutte, et al.Diabetes|August 31, 2010
Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathwayJunlei Chang, Yiming Li, Yu Huang, et al.Cell Reports|June 1, 2022
Muscle satellite cells are impaired in type 2 diabetic mice by elevated extracellular adenosineLifang Han, Gang Wang, Shaopu Zhou, et al.The Biochemical Journal|January 8, 2008
Post-translational modifications of adiponectin: mechanisms and functional implicationsYu Wang, Karen S L Lam, Ming-hon Yau, et al.Trends in Pharmacological Sciences|November 10, 2019
Piezo Ion Channels in Cardiovascular MechanobiologyDominique Douguet, Amanda Patel, Aimin Xu, et al.Expert Review of Endocrinology & Metabolism|February 13, 2019
Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding proteinRuby Lc Hoo, Dennis Cy Yeung, Karen Sl Lam, et al.British Journal of Pharmacology|April 5, 2011
Adiponectin and cardiovascular health: an updateXiaoyan Hui, Karen S L Lam, Paul M Vanhoutte, et al.Journal of Diabetes Investigation|May 21, 2014
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokinesElaine Hui, Aimin Xu, Hong Bo Yang, et al.Basic & Clinical Pharmacology & Toxicology|October 10, 2019
Lipocalin-2-The myth of its expression and functionDahui Li, Wai Yan Sun, Bowen Fu, et al.Biomarkers in Medicine|May 19, 2010
Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokinesAnnette Wk Tso, Aimin Xu, Wing Sun Chow, et al.Pageof 725